InformationSeekingMesolimbicEngagementStudy2

Status Recruiting

Clinical Trial Summary

Participants will complete a treasure task during neuroimaging where they have to learn which keys open a treasure chest, and then they are tested on the contents of the treasure chest.

Clinical Trial Description

Study 2 will use a treasure task (employed in C.2.1.1), in which participants select amongst 3 keys to learn which feature of keys unlocks the treasure chest, revealing a trial unique object image (Fig. 8b). On each encoding trial participants view three multi-featural keys and a treasure chest. Each key varies on three dimensions: color (red, blue, yellow), shape of the handle (square, circle, triangle), and number of ridges (one, two, three). On each trial, all 9 dimensions of the keys are represented, but the dimensions represented on each key are randomized across trials. During hypothesis testing runs, participants are instructed to find the feature of a key that opens the treasure chest to reveal a trial-unique image. Critically, there is one target feature of a key that deterministically opens the treasure chest. The target feature of the key randomly changes after participants successfully open the chest 4 consecutive times. This design manipulates goal-oriented exploration by allowing participants to resolve uncertainty until they identify the target feature of the key. Uncertainty resolution is the greatest after the target features switches and incrementally reduces via individuals' active hypothesis testing. During control runs, participants will be instructed to select specific keys, and key selection and outcomes will be yolked to prior hypothesis testing runs. Participants will complete 3 runs of hypothesis testing runs and 3 control runs. Trial number for each run is determined by participant behavior, in that hypothesis testing runs end when participants complete 4 rule switches (~30 trials). Encoding is incidental in this task. Following encoding, participants will complete an immediate and delayed item memory test. On each trial, participants will view objects from the hypothesis testing and control conditions as well as new foil objects. Memory will be tested for half the stimuli immediately and at a 24-hour delay. These memory measures will be related to uncertainty resolution estimated by reinforcement learning, to determine how prior knowledge during information seeking has subsequent effects on memory. ;

Study Design

Related Conditions & MeSH terms

Motivation

Clinical Trial Details

NCT number	NCT06257433
Study type	Interventional
Source	Temple University
Contact	Vishnu Murty, PhD
Phone	7406328932
Email	vishnu.murty@temple.edu
Status	Recruiting
Phase	N/A
Start date	October 24, 2023
Completion date	August 1, 2026

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04612842` - Engaging Older Adults in Fall Prevention Using Motivational Interviewing (MI)	N/A
Not yet recruiting	`NCT06071130` - Emotion, Aging, and Decision Making	N/A
Recruiting	`NCT06029959` - Stroke and CPAP Outcome Study 3	N/A
Enrolling by invitation	`NCT05547230` - a Research About the Effect of Body Awareness on Work Motivation and Quality of Life, Among Primary School Teachers
Not yet recruiting	`NCT04978194` - Effects of an Intervention on University Students' Mental Health and Learning During COVID-19	N/A
Completed	`NCT04505241` - Evaluating Mechanisms of Action of Adaptive Goal-Setting for Physical Activity	N/A
Completed	`NCT02924025` - Motivational Interviewing as an Intervention for PCOS	N/A
Completed	`NCT01433679` - The Effect of a Web-Based Behavioral Intervention on Physical Activity Levels in Adolescents	N/A
Completed	`NCT00705887` - A Motivational Enhancement Approach to Skin Cancer Prevention	N/A
Completed	`NCT05100524` - Motivational Interview for Daily Living Activities in Elderly People Undergoing Total Knee Replacement	N/A
Completed	`NCT05562245` - Motivational Interviewing-Based Breastfeeding Education	N/A
Completed	`NCT04024371` - Validating Reward-related Biomarkers (RTOC)
Enrolling by invitation	`NCT03328962` - Smoking Cessation in Cancer Treatment	N/A
Recruiting	`NCT05803213` - Learning Efficacy and Motivation of Medical Students in Clinical Training With Virtual Reality	N/A
Completed	`NCT06044090` - Brain and Stress Study	Phase 4
Completed	`NCT04927923` - The Effect of Hope-focused Motivational Interview on Individuals Receiving Hemodialysis Treatment	N/A
Completed	`NCT05499338` - Motivation as a Strategy for Adherence to a Stretching Program for Basketball Players	N/A
Completed	`NCT03681509` - Pramipexole and Emotional Processing	N/A
Recruiting	`NCT05065151` - Understanding Motivation in Parkinson's Patients Through Neurophysiology	N/A
Recruiting	`NCT06257446` - InformationSeekingMesolimbicEngagementStudy1	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.